Published in Stomatol DDR on April 01, 1977
Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion? Nat Med (1996) 5.09
Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study. Lancet (2001) 3.62
Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med (1995) 3.20
A small animal model of human Helicobacter pylori active chronic gastritis. Gastroenterology (1990) 3.03
Helicobacter mustelae-associated gastritis in ferrets. An animal model of Helicobacter pylori gastritis in humans. Gastroenterology (1990) 2.64
Vacuolating cytotoxin of Helicobacter pylori plays a role during colonization in a mouse model of infection. Infect Immun (2001) 2.30
Structure of the Abelson murine leukemia virus genome. Cell (1979) 2.27
Helicobacter pylori gastric infection in gnotobiotic beagle dogs. Infect Immun (1990) 1.88
Transmission of Helicobacter spp. A challenge to the dogma of faecal-oral spread. Epidemiol Infect (1991) 1.58
Inhibition by cyclosporin A of adenosine triphosphate-dependent transport from the hepatocyte into bile. Gastroenterology (1993) 1.58
Helicobacter felis gastritis in gnotobiotic rats: an animal model of Helicobacter pylori gastritis. Infect Immun (1991) 1.51
Identification and propagation of a putative immunosuppressive orphan parvovirus in cloned T cells. J Immunol (1993) 1.49
Helicobacter mustelae-induced gastritis and elevated gastric pH in the ferret (Mustela putorius furo). Infect Immun (1991) 1.46
Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas. Hepatology (1998) 1.46
Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis. Nat Med (1998) 1.42
Fimbrial lectins influence the chemokine repertoire in the urinary tract mucosa. Kidney Int (2007) 1.37
Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes. Hepatology (1990) 1.25
Expression of receptors for advanced glycation end products in peripheral occlusive vascular disease. Am J Pathol (1995) 1.24
Gastric colonization of the ferret with Helicobacter species: natural and experimental infections. Rev Infect Dis (1991) 1.19
Modes of action of aspirin-like drugs. Proc Natl Acad Sci U S A (1985) 1.18
Role of Helicobacter felis in chronic canine gastritis. Vet Pathol (1992) 1.15
Human hepatic preneoplasia: phenotypes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia. Virchows Arch (1997) 1.10
Transarterial chemoembolization (TACE) for inoperable intrahepatic cholangiocarcinoma. Cardiovasc Intervent Radiol (2007) 1.07
Inhibition of neutrophil activation by nonsteroidal anti-inflammatory drugs. Am J Med (1984) 1.06
p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation. Oncogene (1994) 1.06
Structure and expression of the Abelson murine leukemia virus genome and its relationship to a normal cell gene. Cold Spring Harb Symp Quant Biol (1980) 1.05
Uncoupling of XB/U-cadherin-catenin complex formation from its function in cell-cell adhesion. J Biol Chem (1997) 1.04
Cadherin transfection of Xenopus XTC cells downregulates expression of substrate adhesion molecules. Mol Cell Biol (1995) 1.04
Hypertension and hyperlipidaemia: garlic helps in mild cases. Br J Clin Pract Suppl (1990) 1.02
Preservation damage in liver transplantation. Influence of rapid cooling. Transplantation (1986) 1.00
Complement activation during systemic lupus erythematosus. C3a and C5a anaphylatoxins circulate during exacerbations of disease. Arthritis Rheum (1986) 0.99
Image reconstruction with acoustic measurement using distorted Born iteration method. Ultrason Imaging (1996) 0.98
Effect of tauroursodeoxycholic acid on bile acid-induced apoptosis in primary human hepatocytes. Eur J Clin Invest (2000) 0.97
Extrahepatic biliary obstruction impairs microvascular perfusion and increases leukocyte adhesion in rat liver. Hepatology (1997) 0.97
Human APC gene expression in rodent colonic epithelium in vivo using liposomal gene delivery. Hum Mol Genet (1994) 0.96
Correlation of multislice CT and histomorphology in HCC following TACE: predictors of outcome. Cardiovasc Intervent Radiol (2008) 0.95
Preservation damage in liver transplantation: electron-microscopic findings. Transplant Proc (1984) 0.95
[Diagnosis of and therapy for hepatocellular carcinoma]. Z Gastroenterol (2013) 0.91
Expression of MUC1, Thomsen-Friedenreich antigen, Tn, sialosyl-Tn, and alpha2,6-linked sialic acid in hepatocellular carcinomas and preneoplastic hepatocellular lesions. Virchows Arch (1999) 0.91
Tacrolimus monotherapy without steroids after liver transplantation--a prospective randomized double-blinded placebo-controlled trial. Am J Transplant (2007) 0.91
Impact of N-acetylcysteine on the hepatic microcirculation after orthotopic liver transplantation. Transplantation (1996) 0.91
Inhibition of nitric oxide synthesis in ischemia/reperfusion of the rat liver is followed by impairment of hepatic microvascular blood flow. J Hepatol (1997) 0.90
Comparison of resection and transarterial chemoembolisation in the treatment of advanced intrahepatic cholangiocarcinoma--a single-center experience. Eur J Surg Oncol (2013) 0.90
Therapeutic modalities and prognostic factors for primary and secondary liver tumors. World J Surg (1995) 0.90
Influence of the dopamine D2 receptor (DRD2) genotype on neuroadaptive effects of alcohol and the clinical outcome of alcoholism. Pharmacogenetics (1997) 0.89
[Liver transplantation in the GDR]. Khirurgiia (Mosk) (1981) 0.88
Bone disease after liver transplantation. Transplant Proc (1992) 0.88
N-acetylcysteine attenuates the increase in alpha-glutathione S-transferase and circulating ICAM-1 and VCAM-1 after reperfusion in humans undergoing liver transplantation. Transplantation (2001) 0.88
In vivo growth rates are poorly correlated with phage therapy success in a mouse infection model. Antimicrob Agents Chemother (2011) 0.87
Biliary tract strictures after orthotopic liver transplantation: diagnosis and management. Endoscopy (1994) 0.87
Successful treatment of complete inferior vena cava thrombosis after liver transplantation by thrombolytic therapy. Br J Surg (1992) 0.87
Improvement of hepatic microhemodynamics by N-acetylcysteine after warm ischemia. Eur Surg Res (1996) 0.87
Liver transplantation for hepatocellular carcinoma--is there a risk of recurrence caused by intraoperative blood salvage autotransfusion? Eur Surg Res (2011) 0.87
Fatal hepatic necrosis after isoflurane anaesthesia. Anaesthesia (1997) 0.86
The efficacy of N-acetylcysteine as a hepatoprotective agent in liver transplantation. Transpl Int (1998) 0.86
Role of hepatitis C virus infection in German patients with fulminant and subacute hepatic failure. Eur J Clin Invest (1992) 0.86
Analysis of extravascular endothelin levels in UW solution and rinsing effluent of porcine liver grafts after cold storage. Transplant Proc (1995) 0.86
Prostanoid release in experimental liver transplantation. Transplantation (1990) 0.86
Incidence of pressure ulcers in a neurologic intensive care unit. Crit Care Med (2001) 0.86
Overexpression of p53 protein is not directly related to hepatitis B x protein expression and is associated with neoplastic progression in hepatocellular carcinomas rather than hepatic preneoplasia. Mutat Res (2000) 0.85
Neurological complications in the European multicentre study of FK 506 and cyclosporin in primary liver transplantation. Transpl Int (1994) 0.85
Liver transplantation for hilar cholangiocarcinoma: a German survey. Transplant Proc (2008) 0.85
Liver transplantation in Crigler-Najjar syndrome. A case report. Transplantation (1986) 0.85
Flow and pressure during liver preservation under ex situ and in situ perfusion with University of Wisconsin solution and histidine-tryptophan-ketoglutarate solution. Eur Surg Res (2007) 0.84
Clinical value of cytokine determination for screening, differentiation, and therapy monitoring of infectious and noninfectious complications after orthotopic liver transplantation. Transplant Proc (1991) 0.84
Excessive urinary oxalate excretion after combined renal and hepatic transplantation for correction of hyperoxaluria type 1. Eur J Pediatr (1990) 0.84
Loss of CD95 expression is linked to most but not all p53 mutants in European hepatocellular carcinoma. J Mol Med (Berl) (2001) 0.84
[Acute haemoperitoneum due to spontaneous tumour rupture as first manifestation of hepatocellular carcinoma]. Z Gastroenterol (2007) 0.84
Increased medication compliance of liver transplant patients switched from a twice-daily to a once-daily tacrolimus-based immunosuppressive regimen. Transplant Proc (2013) 0.84
Complement inhibition by soluble complement receptor type 1 improves microcirculation after rat liver transplantation. Transplantation (1998) 0.84
Rapid increase in the activity of enzymes of eicosanoid synthesis in hepatic and extrahepatic tissues after experimental liver transplantation. Transplantation (1991) 0.83
[Medical history significance of the last Mozart portrait--a deathly serious impetus for smiling and reflection]. Z Arztl Fortbild (Jena) (1992) 0.83
[Arterial back table pressure perfusion prevents ischemic biliary lesions after orthotopic liver transplantation]. Chirurg (2003) 0.83
Acute renal failure and liver dysfunction after subcutaneous injection of 3-sn-phosphatidylcholine (Lipostabil®)-case report. Z Gastroenterol (2011) 0.83
Psychological conflicts between relatives during the long-term course after successful living organ donation. Transplant Proc (2008) 0.83
Surgical therapy of neuroendocrine neoplasm with hepatic metastasis: patient selection and prognosis. Langenbecks Arch Surg (2015) 0.83
Two-year data from the European multicentre tacrolimus (FK506) liver study. Transpl Int (1996) 0.82
Oral administration of a matrix metalloproteinase inhibitor, CGS 27023A, protects the cartilage proteoglycan matrix in a partial meniscectomy model of osteoarthritis in rabbits. Inflamm Res (1995) 0.82
Evaluation of preservation damage after porcine liver transplantation by assessment of hepatic microcirculation. Transplantation (1990) 0.82
[TACE: therapy of the HCC before liver transplantation--experiences]. Rofo (2005) 0.82
Destruction of Kupffer's cells increases total liver blood flow and decreases ischemia reperfusion injury in pigs. Transplant Proc (1999) 0.82
Recovery time and safe discharge of endoscopy patients after conscious sedation. Gastroenterol Nurs (1997) 0.82
Ischemic type biliary lesions in histidine-tryptophan-ketoglutarate (HTK) preserved liver grafts. Int J Artif Organs (2006) 0.82
Cytokeratin expression is reduced in glycogenotic clear hepatocytes but increased in ground-glass cells in chronic human and woodchuck hepadnaviral infection. Hepatology (1998) 0.82
[Further follow-up studies of the treated narrow jaw]. Fortschr Kieferorthop (1967) 0.82
Soluble thrombomodulin--a marker of reperfusion injury after orthotopic liver transplantation. Transplantation (1995) 0.81
Treatment of metachronous and simultaneous liver metastases of pancreatic cancer. Eur Surg Res (2010) 0.81
Biliary complications after prolonged University of Wisconsin preservation of liver allografts. Transplant Proc (1993) 0.81
Focal hepatic glycogenosis. Int J Oncol (1997) 0.81
Optimal FK 506 dosage in patients under primary immunosuppression following liver transplantation. Transpl Int (1994) 0.80
Thermodiffusion as a novel method for continuous monitoring of the hepatic microcirculation after liver transplantation. Transplant Proc (1995) 0.80
Proliferative colitis in ferrets: epithelial dysplasia and translocation. Vet Pathol (1989) 0.80
[Animal experimental technic for the testing of antimycotics]. Z Haut Geschlechtskr (1968) 0.80
The role of monocyte chemoattractant protein-1 in orthotopic liver transplantation. Transplant Proc (2003) 0.80
Effects of Carolina rinse and adenosine rinse on microvascular perfusion and intrahepatic leukocyte-endothelium interaction after liver transplantation in the rat. Transplantation (1993) 0.80
[Surgical treatment of gastric cancer-personal results (author's transl)]. Arch Geschwulstforsch (1976) 0.80
Organ recipients suffering from undifferentiated neuroendocrine small-cell carcinoma of donor origin: a case report. Transplant Proc (2009) 0.80
Recurrence of hepatitis C virus infection after orthotopic liver transplantation. Transplantation (1992) 0.80
Early assessment of reperfusion injury by intraoperative quantification of hepatic microcirculation in patients. Transplant Proc (1997) 0.79
Modulation of the CD2 receptor and not disruption of the CD2/CD48 interaction is the principal action of CD2-mediated immunosuppression in the rat. Cell Immunol (1997) 0.79